/logo.svgIpoTec


Avience Biomedicals Ipo


Avience Biomedicals IPO Review & Key Points

  • Review: Neutral

Peer Group Comparison

  • There are no listed companies.

IPO Lead Managers aka Merchant Bankers

  • Fintellectual Corporate Advisors Pvt. Ltd.

Name of the Company Face Value (₹) EPS basic (₹)  EPS Diluted (₹) RONW (%) P/E Ratio NAV (₹)
Powerica Limited 5 15.26  15.26 15.37 %  24.45 99.76
Listed Peers
Cummins India Limited 2 72.15  72.15 26.45% 64.13  272.78
Kirloskar Oil Engines Limited 2 33.71 33.60 15.85% 43.24 212.60
NTPC Green Energy Limited 10 0.67 0.67 2.58% 129.40 21.88
Acme Solar Holdings Limited 2 4.55 4.53 5.59% 50.74  74.54
Adani Green Energy Limited 10 8.37 8.37 11.90%  101.53  76.62

IPO Open DateJune 18, 2026
IPO Close DateJune 22, 2026
Face Value₹10 Per Equity Share
IPO Price Band₹196 to ₹208 Per Share
Issue SizeApprox ₹30.24 Crores
Fresh IssueApprox ₹30.24 Crores
Issue TypeBookbuilding Issue
IPO ListingNSE SME
DRHP Draft Prospectus
RHP Draft Prospectus

ApplicationLot SizeSharesAmount
Retail Minimum21,200₹2,49,600
Retail Maximum21,200₹2,49,600
S-HNI Minimum31,800₹3,74,400
S-HNI Maximum84,800₹9,98,400
B-HNI Minimum95,400₹11,23,200

Investor CategoryShare Offered Shares (%)
Anchor Investor4,09,800 Shares28.19%
QIB (Ex. Anchor)2,73,600 Shares18.82%
NII Shares Offered2,07,000 Shares14.24%
Retail Shares Offered4,81,200 Shares33.10%

Anchor Bidding DateJune 17, 2026
Anchor Investors List
Shares Offered4,09,800 Shares
Anchor Size8.52 Cr.
lock-in period end date 50% shares (30 Days) July 23, 2026
lock-in period end date 50% shares (90 Days) Sep 21, 2026

IPO Open Date:June 18, 2026
IPO Close Date:June 22, 2026
Basis of Allotment:June 23, 2026
Refunds:June 24, 2026
Credit to Demat Account:June 24, 2026
IPO Listing Date:June 25, 2026
IPO Bidding Cut-off Time:June 22, 2026 – 5 PM

ParticularShares% Share
Promoter Holding Pre Issue40,31,256 87.89%
Promoter Holding Post Issue54,85,056 64.59%

PurposeCrores
Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh₹15.96
Funding the working capital requirements of the Company₹8.25
General Corporate Purpose₹-

Period EndedRevenueExpensePATAssets
2024₹24.37₹21.43₹2.14₹34.65
2025₹45.97₹36.17₹7.23₹56.52
Jan 2026₹41.94₹34.06₹5.74₹66.07

KPIValues
ROE:-%
ROCE:24.88%
EBITDA Margin:25.22%
PAT Margin:15.86%
Debt to equity ratio: 0.97
Earning Per Share (EPS):₹19.06 (Basic)
Price/Earning P/E Ratio:N/A
Return on Net Worth (RoNW):49.89%
Net Asset Value (NAV):₹56.50

Period Ended Revenue Expense PAT Assets
2023 ₹184.81 ₹154.97 ₹32.10 ₹251.58
2024 ₹206.45 ₹175.85 ₹34.44 ₹339.25
2025 ₹322.58 ₹261.43 ₹28.13 ₹455.49
Dec 2025 ₹236.50 ₹186.96 ₹38.69 ₹561.34

Disclaimer:Logos and other registered trademarks of funds used on this platform are held by their respective owners. IpoTec does not claim ownership or association on them, and their use is purely for informational and illustrative purposes.

Copyrights ©2026 IpoTec. All rights reserved.